AbCellera Biologics Inc.
ABCL
Peringkat dalam Saham
#4228
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the... AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
Harga Saham
$11.65
Kapitalisasi Pasar
$3.77B
Perubahan (1 hari)
-2.39%
Perubahan (1 tahun)
98.72%
Negara
CA
Perdagangan AbCellera Biologics Inc. (ABCL)
Kategori
Healthcare
Jumlah saham beredar untuk AbCellera Biologics Inc. (ABCL)
Jumlah saham beredar per June 2026: 305.56M
Menurut laporan keuangan terbaru dan harga saham AbCellera Biologics Inc., jumlah saham beredar saat ini adalah 305.56M. Pada akhir December 2023, perusahaan memiliki 289.17M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk AbCellera Biologics Inc. (ABCL) dari 2018 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2026 (TTM) | 305.56M | 3.82% |
| 2024 | 294.33M | 1.78% |
| 2023 | 289.17M | 1.44% |
| 2022 | 285.06M | 3.37% |
| 2021 | 275.76M | 2.96% |
| 2020 | 267.82M | 24.33% |
| 2019 | 215.41M | 42.60% |
| 2018 | 151.06M | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| 253.90M | -16.91% |
US
|
|
| 396.00M | 29.60% |
US
|
|
| 478.91M | 56.73% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -79.65% |
NL
|
